Hand-out
Press Releases
LIPOGEMS ANNOUNCES ENROLLMENT OF THE FINAL PATIENT IN ARISE FDA CLINICAL TRIALS FOR KNEE OSTEOARTHRITIS
ATLANTA, March 5, 2025 /PRNewswire/ -- Lipogems has announced the final patient enrolled in the ARISE II U.S. FDA IDE Study, which aims to evaluate the efficacy and safety of
